دورية أكاديمية
أعرض في EDS

Human Seroprevalence for Dengue, Ross River, and Barmah Forest viruses in Australia and the Pacific: A systematic review spanning seven decades.

التفاصيل البيبلوغرافية
العنوان: Human Seroprevalence for Dengue, Ross River, and Barmah Forest viruses in Australia and the Pacific: A systematic review spanning seven decades.
المؤلفون: Madzokere ET; Institute for Glycomics, Griffith University, Gold Coast Campus, Southport, Australia., Qian W; Centre for Clinical Research, University of Queensland, Brisbane, Australia., Webster JA; Institute for Glycomics, Griffith University, Gold Coast Campus, Southport, Australia.; QIMR Berghofer Medical Research Institute, Brisbane, Australia., Walker DMH; Institute for Glycomics, Griffith University, Gold Coast Campus, Southport, Australia., Lim EXY; Institute for Glycomics, Griffith University, Gold Coast Campus, Southport, Australia., Harley D; Centre for Clinical Research, University of Queensland, Brisbane, Australia., Herrero LJ; Institute for Glycomics, Griffith University, Gold Coast Campus, Southport, Australia.
المصدر: PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2022 Apr 29; Vol. 16 (4), pp. e0010314. Date of Electronic Publication: 2022 Apr 29 (Print Publication: 2022).
نوع المنشور: Journal Article; Review; Systematic Review
اللغة: English
بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101291488 Publication Model: eCollection Cited Medium: Internet ISSN: 1935-2735 (Electronic) Linking ISSN: 19352727 NLM ISO Abbreviation: PLoS Negl Trop Dis Subsets: MEDLINE
أسماء مطبوعة: Original Publication: San Francisco, CA : Public Library of Science
مواضيع طبية MeSH: Alphavirus* , Arboviruses* , Culicidae* , Dengue*/epidemiology, Animals ; Australia/epidemiology ; Chickens ; Forests ; Humans ; Seroepidemiologic Studies
مستخلص: Background: Dengue (DENV), Ross River (RRV) and Barmah Forest viruses (BFV) are the most common human arboviral infections in Australia and the Pacific Island Countries and Territories (PICTs) and are associated with debilitating symptoms. All are nationally notifiable in Australia, but routine surveillance is limited to a few locations in the PICTs. Understanding the level of human exposure to these viruses can inform disease management and mitigation strategies. To assess the historic and current seroprevalence of DENV, RRV and BFV in Australia and the PICTs we conducted a systematic literature review of all published quantitative serosurveys.
Methodology and Principal Findings: The Preferred Reporting of Items for Systematic Reviews and Meta-Analyses procedures were adopted to produce a protocol to systematically search for published studies reporting the seroprevalence of DENV, RRV and BFV in Australia and the PICTs. Data for author, research year, location, study population, serosurvey methods and positive tests were extracted. A total of 41 papers, reporting 78 serosurveys of DENV, RRV and BFV including 62,327 samples met the inclusion criteria for this review. Seroprevalence varied depending on the assay used, strategy of sample collection and location of the study population. Significant differences were observed in reported seropositivity depending on the sample collection strategy with clinically targeted sampling reporting the highest seroprevalence across all three viruses. Non-stratified seroprevalence showed wide ranges in reported positivity with DENV 0.0% - 95.6%, RRV 0.0% - 100.0%, and BFV 0.3% - 12.5%. We discuss some of the causes of variation including serological methods used, selection bias in sample collection including clinical or environmental associations, and location of study site. We consider the extent to which serosurveys reflect the epidemiology of the viruses and provide broad recommendations regarding the conduct and reporting of arbovirus serosurveys.
Conclusions and Significance: Human serosurveys provide important information on the extent of human exposure to arboviruses across: (1) time, (2) place, and (3) person (e.g., age, gender, clinical presentation etc). Interpreting results obtained at these scales has the potential to inform us about transmission cycles, improve diagnostic surveillance, and mitigate future outbreaks. Future research should streamline methods and reduce bias to allow a better understanding of the burden of these diseases and the factors associated with seroprevalence. Greater consideration should be given to the interpretation of seroprevalence in studies, and increased rigour applied in linking seroprevalence to transmission dynamics.
Competing Interests: The authors have declared that no competing interests exist.
References: Med J Aust. 1981 Jul 11;2(1):17-9. (PMID: 7278766)
Am J Trop Med Hyg. 1981 Sep;30(5):1053-9. (PMID: 7283004)
Epidemiol Infect. 1991 Oct;107(2):435-40. (PMID: 1657626)
Vaccine. 2012 Jun 29;30(31):4638-43. (PMID: 22583812)
Aust J Exp Biol Med Sci. 1982 Oct;60 (Pt 5):457-70. (PMID: 6299258)
Lancet Infect Dis. 2017 Mar;17(3):e101-e106. (PMID: 28011234)
Am J Trop Med Hyg. 1979 Mar;28(2):351-63. (PMID: 453438)
Med J Aust. 1987 Jun 1;146(11):569-73. (PMID: 3039324)
Med J Aust. 1990 May 7;152(9):463-6. (PMID: 2166224)
Trop Med Health. 2020 May 15;48:33. (PMID: 32435149)
Emerg Infect Dis. 2018 Mar;24(3):558-561. (PMID: 29460745)
Med J Aust. 1974 Oct 12;2(15):552-6. (PMID: 4473695)
PLoS One. 2017 Oct 2;12(10):e0185551. (PMID: 28968420)
Med J Aust. 1977 Apr 30;1(18):649-51. (PMID: 875818)
Annu Rev Entomol. 2008;53:273-91. (PMID: 17803458)
PLoS Med. 2009 Jul 21;6(7):e1000097. (PMID: 19621072)
Trends Microbiol. 2020 Apr;28(4):276-292. (PMID: 31864844)
Am J Trop Med Hyg. 1973 Jul;22(4):543-50. (PMID: 4197954)
Nat Microbiol. 2019 Jan;4(1):20-34. (PMID: 30150735)
Am J Trop Med Hyg. 1975 Jul;24(4):664-75. (PMID: 1155702)
PLoS Negl Trop Dis. 2017 Aug 14;11(8):e0005785. (PMID: 28806786)
Gates Open Res. 2018 Nov 1;2:36. (PMID: 30596205)
Trans R Soc Trop Med Hyg. 1968;62(6):862-7. (PMID: 4389154)
PLoS Negl Trop Dis. 2017 Apr 24;11(4):e0005488. (PMID: 28437465)
Emerg Infect Dis. 2017 Oct;23(10):1751-1753. (PMID: 28930020)
J Vector Borne Dis. 2008 Sep;45(3):245-8. (PMID: 18807382)
Viruses. 2020 Jul 06;12(7):. (PMID: 32640629)
Emerg Infect Dis. 2019 Apr;25(4):827-830. (PMID: 30882332)
Front Microbiol. 2019 Dec 06;10:2818. (PMID: 31866981)
Eur J Clin Microbiol Infect Dis. 2012 Jun;31(6):1203-10. (PMID: 21983919)
PLoS One. 2013 Sep 25;8(9):e75670. (PMID: 24086608)
Aust N Z J Med. 1986 Feb;16(1):52-7. (PMID: 3010928)
Med J Aust. 1993 Aug 2;159(3):159-62. (PMID: 8393128)
PLoS Negl Trop Dis. 2018 Jul 17;12(7):e0006637. (PMID: 30016372)
N S W Public Health Bull. 2003 Nov-Dec;14(11-12):224-6. (PMID: 14981558)
P N G Med J. 2001 Mar-Jun;44(1-2):43-7. (PMID: 12418677)
Int J Infect Dis. 2015 Aug;37:19-24. (PMID: 26086687)
Parasit Vectors. 2018 Mar 19;11(1):188. (PMID: 29554936)
Emerg Infect Dis. 2013 May;19(5):787-9. (PMID: 23648012)
PLoS Negl Trop Dis. 2021 Mar 11;15(3):e0009259. (PMID: 33705409)
Clin Microbiol Rev. 2001 Oct;14(4):909-32, table of contents. (PMID: 11585790)
Trop Med Int Health. 2006 Aug;11(8):1238-55. (PMID: 16903887)
Aust J Exp Biol Med Sci. 1982 Dec;60(6):701-6. (PMID: 6303286)
Int J Infect Dis. 2017 Apr;57:73-76. (PMID: 28188934)
N Z Med J. 1994 Nov 9;107(989):448-50. (PMID: 7970354)
Trans R Soc Trop Med Hyg. 1973;67(2):197-205. (PMID: 4784056)
Am J Trop Med Hyg. 1998 Sep;59(3):457-61. (PMID: 9749644)
Aust J Exp Biol Med Sci. 1976 Oct;54(5):505-12. (PMID: 1021093)
P N G Med J. 1997 Mar;40(1):14-25. (PMID: 10365566)
Aust J Exp Biol Med Sci. 1966 Aug;44(4):365-77. (PMID: 6007741)
Antiviral Res. 2018 Aug;156:80-84. (PMID: 29906475)
Ecohealth. 2015 Jun;12(2):347-53. (PMID: 25537629)
Med J Aust. 1994 Apr 18;160(8):494-9. (PMID: 8170425)
Vector Borne Zoonotic Dis. 2008 Apr;8(2):283-97. (PMID: 18279007)
Emerg Infect Dis. 2013 Feb;19(2):324-6. (PMID: 23343610)
PLoS One. 2021 Jul 8;16(7):e0253953. (PMID: 34237098)
Int J Infect Dis. 2015 Dec;41:11-2. (PMID: 26482390)
Aust J Exp Biol Med Sci. 1986 Jun;64 ( Pt 3):307-9. (PMID: 3767767)
Int J Infect Dis. 2020 Jan;90:223-225. (PMID: 31689529)
تواريخ الأحداث: Date Created: 20220429 Date Completed: 20220517 Latest Revision: 20230804
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC9094520
DOI: 10.1371/journal.pntd.0010314
PMID: 35486651
قاعدة البيانات: MEDLINE
الوصف
تدمد:1935-2735
DOI:10.1371/journal.pntd.0010314